Abstract
Endothelins (ET) have opposite vascular effects mediated through different receptors: ETA receptors mediating vasoconstriction and ETB receptors mediating vasoconstriction as well as vasodilation. The role of ET in acute hypoxic pulmonary vasoconstriction (HPV) was studied after dual ET receptor blockade with bosentan and nitric oxide (NO) synthase inhibition with nitro-L-arginine (L-NA). We started from the hypothesis that ET antagonism may inhibit HPV but, if not, would do so after NO synthase inhibition. HPV was evaluated in anesthetized lambs, with an intact pulmonary circulation, by the increase in the mean pulmonary artery pressure (Ppa) minus occluded Ppa (Ppao) gradient in response to hypoxia (inspiratory oxygen fraction of 0.1) at different levels of pulmonary flow (multipoint pressure/flow relationships). ET receptor antagonism decreased pulmonary and systemic vascular tone both in hyperoxia and hypoxia. ET antagonism had no effect on HPV. NO synthase inhibition increased pulmonary vascular tone more in hypoxia than in hyperoxia so that HPV was enhanced. After L-NA, bosentan still decreased pulmonary vascular tone in hypoxia but did not affect the magnitude of HPV. The present results suggest that ET and NO are involved in the regulation of basal pulmonary vascular tone. Furthermore, the vasodilator effect of bosentan persisted in the presence of NO synthase inhibition, suggesting a non NO-dependent vasodilator mechanism. The results from these experiments are in agreement with the idea that ET do not play a major role in HPV in the perinatal lamb, even when it is enhanced by NO synthase inhibition.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ET:
-
endothelin
- Fio2:
-
inspired oxygen fraction
- HPV:
-
hypoxic pulmonary vasoconstriction
- L-NA:
-
nitro-L-arginine
- NO:
-
nitric oxide
- Ppa:
-
pulmonary artery pressure
- Ppao:
-
occluded Ppa
- Psa:
-
systemic arterial pressure
- PVR:
-
pulmonary vascular resistance
- Q:
-
cardiac output
References
Yanagisawa M, Masaki T 1989 Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38: 1877–1883
Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Temma S, Matsumura M, Ueda T, Shirakami G, Imura H, Mikawa H 1991 Plasma endothelin levels in healthy children: high values in early infancy. J Cardiovasc Pharmacol 17: S404–S405
Ekblad H, Arjamaa O, Vuolteenaho O, Kaapa P, Kero P 1993 Plasma endothelin-1 concentrations at different ages during infancy and childhood. Acta Paediatr 82: 302–303
Haegerstrand A, Hemsen A, Gillis C, Larsson O, Lundberg J 1989 Endothelin: presence in umbilical vessels, high level in fetal blood and potent vasoconstrictor effect. Acta Physiol Scand 137: 541–542
Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH 1993 Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 148: 519–522
Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H 1991 Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 84: 2280–2285
Widlitz A, Barst RJ 2003 Pulmonary arterial hypertension in children. Eur Respir J 21: 155–176
Michael JR, Markewitz BA 1996 Endothelins and the lung. Am J Respir Crit Care Med 154: 555–581
Shetty SS, Okada T, Webb RL, DelGrande D, Lappe RW 1993 Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 191: 459–464
Sato K, Morio Y, Morris KG, Rodman DM, McMurtry IF 2000 Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel. Am J Physiol Lung Cell Mol Physiol 278: L434–L442
Ivy D, McMurtry IF, Yanagisawa M, Gariepy CE, Le Cras TD, Gebb SA, Morris KG, Wiseman RC, Abman SH 2001 Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Mol Physiol 280: L1040–1048.
Fujii Y, Magder S, Cernacek P, Goldberg P, Guo Y, Hussain SN 2000 Endothelin receptor blockade attenuates lipopolysaccharide-induced pulmonary nitric oxide production. Am J Respir Crit Care Med 161: 982–989
Wong J, Fineman JR, Heymann MA 1994 The role of endothelin and endothelin receptors subtypes in the regulation of fetal pulmonary vascular tone. Pediatr Res 35: 664–670
Wong J, Vanderford PA, Winters JW, Chang R, Soifer SJ, Fineman JR 1993 Endothelin-1 does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb. J Cardiovasc Pharmacol 22: S262–S266
Wong J, Vanderford PA, Fineman JR, Chang R, Soifer SJ 1993 Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am J Physiol 265: H1318–H1325
Wong J, Vanderford PA, Winters J, Soifer SJ, Fineman JR 1995 Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J Cardiovasc Pharmacol 25: 207–215
Wang Y, Coe Y, Toyoda O, Coceani F 1995 Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb. J Physiol 482: 421–434
Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR 2000 Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97–106
Kourembanas S, Marsden PA, McQuillan LP, Faller DV 1991 Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88: 1054–1057
Shirakami G, Nakao K, Saito Y, Magaribuchi T, Jougasaki M, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y, et al. 1991 Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 48: 969–976
Elton TS, Oparil S, Taylor GR, Hicks PH, Yang RH, Jin H, Chen YF 1992 Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol 263: 1260–1264
Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF 1995 Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 268: L95–L100
Bonvallet ST, Zamora MR, Hasunuma K, Sato K, Hanasato N, Anderson D, Stelzner TJ 1994 BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 266: H1327–H1331
Leeman M, de Beyl VZ, Biarent D, Maggiorini M, Mélot C, Naeije R 1999 Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced lung injury. Am J Respir Crit Care Med 159: 1383–1390
Fineman JR, Heymann MA, Soifer SJ 1991 N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol 260: H1299–H1306
Gordon JB, Tod ML 1993 Effects of N omega-nitro-L-arginine on total and segmental vascular resistances in developing lamb lungs. J Appl Physiol 75: 76–85
Tod ML, Cassin S 1992 Endothelin-1-induced pulmonary arterial dilation is reduced by N omega-nitro-L-arginine in fetal lambs. J Appl Physiol 72: 1730–1734
Hubloue I, Biarent D, Abdel Kafi S, Bejjani G, Kerbaul F, Naeije R, Leeman M 2003 Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction. Eur Respir J 21: 19–24
Hubloue I, Biarent D, Abdel Kafi S, Bejjani G, Mélot C, Naeije R, Leeman M 2003 Endothelin receptor blockade in canine oleic acid-induced lung injury. Intensive Care Med 29: 1003–1006
Fischer SR, Traber DL 1999 L-Arginine and endothelin receptor antagonist bosentan counteract hemodynamic effects of modified hemoglobin. Shock 11: 283–290
Cornfield DN, Chatfield BA, McQueston JA, McMurtry IF, Abman SH 1992 Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 262: H1474–H1481
Mitzner W 1983 Resistance of the pulmonary circulation. Clin Chest Med 4: 127–137
Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W, et al. 1994 Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228–235
Coe Y, Haleen SJ, Welch KM, Liu YA, Coceani F 2002 The endothelin A receptor antogonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb. J Pharmacol Exp Ther 302: 672–680
Coe Y, Haleen SJ, Welch KM, Coceani F 2000 The endothelin-A-receptor antagonist PD 180988 (CI-1034) selectively reverses the pulmonary vasoconstrictor response to hypoxia in lamb. J Cardiovasc Pharmacol 36: S331–S333
Galie N, Manes A, Branzi A 2004 The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227–237
Barnes PJ, Liu SF 1995 Regulation of pulmonary vascular tone. Pharmacol Rev 47: 87–131
Lazor R, Feihl F, Waeber B, Kucera P, Perret C 1996 Endothelin-1 does not mediate the endothelium-dependent hypoxic contractions of small pulmonary arteries in rats. Chest 110: 189–197
Takeoka M, Ishizaki T, Sakai A, Chang SW, Shigemori K, Higashi T, Ueda G 1995 Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol Scand 155: 53–60
Douglas SA, Vickery-Clark LM, Ohlstein EH 1993 Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123. Br J Pharmacol 108: 418–421
Acknowledgements
The authors thank Marie-Thérèse Gautier for her expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grant no. 3.4567.00 from the Fonds de la Recherche Scientifique Médicale (Belgium). Bosentan was a generous gift from Dr. Martine Clozel (Actelion, Allschwil, Switzerland).
Rights and permissions
About this article
Cite this article
Biarent, D., Hubloue, I., Bejjani, G. et al. Role of Endothelins and Nitric Oxide in the Pulmonary Circulation of Perinatal Lambs During Hyperoxia and Hypoxia. Pediatr Res 59, 131–136 (2006). https://doi.org/10.1203/01.pdr.0000191138.34387.e2
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000191138.34387.e2
